In 2026, most psychedelic research will focus on two big questions: do these drugs calm harmful brain inflammation, and do they physically rebuild broken connections between brain cells? These aren't just academic questions — they could explain why psychedelics seem to help with depression, PTSD, and addiction in ways that standard drugs don't. Understanding the 'why' is a crucial step toward making treatments safer and more predictable.
Today's signals cluster tightly around inflammation and plasticity pathways — the field's clearest mechanistic frontier.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →